CGNX
Cognex Corporation
CGNX's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CGNX overall, supported by stronger valuation and stronger modeled upside.
CGNX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CGNX's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CGNX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 26x | $50.77 | — |
| Current | 35x | $50.77 | — |
| Cheap | 40x | $57.69 | +14% |
| Fair | 55x | $79.70 | +57% |
| Expensive | 79x | $113 | +123% |
Historical ranges are pointers, not guarantees.
CGNX's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 26x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CGNX in the historical PE scenario, which offers more potential upside but is not a forecast.
CGNX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
CGNX has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CGNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.94 | +35% |
| Q3 2026 | $1.44 | +122% |
| Q2 2026 | $1.04 | +44% |
| Q1 2026 | $0.85 | +23% |
| Q4 2025 | $0.68 | +9.7% |
| Q3 2025 | $0.65 | +27% |
| Q2 2025 | $0.72 | +60% |
| Q1 2025 | $0.69 | +21% |
| Q4 2024 | $0.62 | -4.6% |
CGNX earned $1.44 per share over the past year, up 122% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CGNX on earnings, with more consistent year-over-year improvement.
CGNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $313.4M | +13% |
| Q2 2026 | $291.3M | +17% |
| Q1 2026 | $268.4M | +24% |
| Q4 2025 | $252.3M | +9.9% |
| Q3 2025 | $276.9M | +18% |
| Q2 2025 | $249.1M | +4.1% |
| Q1 2025 | $216M | +2.5% |
| Q4 2024 | $229.7M | +17% |
CGNX's revenue has grown year over year for nine quarters in a row: $313M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +11 points |
| Q2 2026 | 29% | +12 points |
| Q1 2026 | 22% | +10 points |
| Q4 2025 | 14% | +0.6 points |
| Q3 2025 | 21% | +7.4 points |
| Q2 2025 | 17% | +1.4 points |
| Q1 2025 | 12% | +5.3 points |
| Q4 2024 | 13% | +7 points |
CGNX's operating margin was 32% last quarter, up 11 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CGNX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CGNX on profitability, with a higher operating margin.
CGNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.8M | +21% |
| Q2 2026 | $67.6M | +67% |
| Q1 2026 | $42.3M | +11% |
| Q4 2025 | $72.3M | +47% |
| Q3 2025 | $86M | +66% |
| Q2 2025 | $40.4M | +74% |
| Q1 2025 | $38M | +297% |
| Q4 2024 | $49.3M | +560% |
CGNX's free cash flow has been positive every quarter for seven years: $286M over the past year, up 34% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
CGNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +1M shares |
| 1 year | +1% | +1.7M shares |
| 3 years | -1.3% | -2.3M shares |
| 5 years | -5.2% | -9.3M shares |
| Available history | -2.4% | -4.2M shares |
CGNX has 171M diluted shares, up 1% from a year ago, despite $130M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6.2M |
| Q1 2026 | $99M |
| Q4 2025 | $25M |
| Q3 2025 | $24M |
| Q2 2025 | — |
| Q1 2025 | $102.2M |
| Q4 2024 | $43.2M |
CGNX spent $130M buying back its own shares over the past year, down 23% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CGNX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CGNX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
CGNX has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CGNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 13.4 | Oversold |
CGNX's weekly RSI is 41 (neutral) and its Stochastic is 13 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CGNX PE vs Technology Sector
| Metric | CGNX | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 27% above |
| PE % | 8 | 35 | 27 pts below |
CGNX is trading at 35x earnings, a 27% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CGNX on valuation relative to its sector.
CGNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.4 | 9.9% below |
| 20 week MA | $60.9 | 17% below |
| 50 week MA | $55.1 | 7.8% below |
| 100 week MA | $45.6 | 11% above |
| 200 week MA | $44.9 | 13% above |
CGNX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CGNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.2 | $80.7 | +44% |
| 2021 | $80.7 | $77.6 | -3.9% |
| 2022 | $77.6 | $47.4 | -39% |
| 2023 | $47.4 | $41.7 | -12% |
| 2024 | $41.7 | $36.0 | -14% |
| 2025 | $36.0 | $36.6 | +1.4% |
| 2026 YTD | $36.6 | $50.8 | +39% |
CGNX has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.